Amgen declared that data from two new studies suggest barriers to access for PCSK9 inhibitors Read more
Regeneron and Sanofi declare plans to make Praluent more accessible for patients at high risk Read more
Abbott’s HeartMate 3 Heart Pump displays enhanced survival and lower rates of Stroke and Pump Thrombosis Read more
Janssen Pharmaceutical’s INVOKANA alleviates risk of CV death or HHF in type 2 diabetes patients Read more